Following a successful launch last year, the Bionow BioAI Summit returned to Alderley Park on 29th April. The event welcomed over 100 delegates, speakers and exhibitors, all coming together to explore where artificial intelligence can deliver the most meaningful impact within the life sciences sector.
The agenda was led by experts from industry, academia, and healthcare, exploring topics including the applications of AI in general, as well as in R&D and Regulation & Validation, through a series of presentations and panel discussions.
Insightful keynote sessions were conducted by Gary Leeming, Deputy Director for the Civic Health Innovation Labs at the University of Liverpool, and Professor Jonathan Heddle, Founder of nCage Therapeutics and Lab Head at Durham University.
Read the full event summary here
The 2026 BioAI Summit was sponsored by Appleyard Lees and Bruntwood SciTech.
Agenda highlights:
Keynote Speakers
- Gary Leeming, Deputy Director for the Civic Health Innovation Labs at University of Liverpool
- Jonathan Heddle, Professor & Founder of nCage Therapeutics at Durham University
State of The BioAI Nation Panel
Chair: Paul Roscoe, Partner, Appleyard Lees
Speakers
- Dave Burrows, Founder, Leading Logic
- Magnus Rattray, Professor of Computational & Systems Biology, University of Manchester
- Isabel Vincent, Market Development Manager, Firefinch Software Development
- Dan O’Connor, Regulatory Policy & Early Access Director, The Association of the British Pharmaceutical Industry (ABPI)
Allan Jordan, Vice President & Director, Sygnature Discovery
AI in R&D Presentations
Speakers
- Sam Whitmarsh, Director of Analytical Science & Digital Transformation, CatSci
- Stefan Bostock, CEO & Co-Founder, Danu Insights
- James McDonagh, Principal Applied AI Scientist, ApconiX
- Dominic Mosses, CEO & Founder, Protostem-AI
Applications of AI Presentations
Speakers
- Tim Eyes, Co-Founder & Director of Programs, Imperagen
- Emma Hodson-Tole, Professor of Neuromuscular Biomechanics, Manchester Metropolitan University
- Chuin Hong Yap, Senior Research Associate, Manchester Metropolitan University
- Micheal Abaho, NLP (AI) Lead Scientist (CHIL LAB), University of Liverpool
Regulation & Validation Panel
Chair: Stephanie Caird, Partner, Mills & Reeve
Speakers
- Paul Irving, Principal Consultant & Owner, Northern Life Sciences Ltd (Team-Compliance)
- Stephanie-Jayne Jones, Chief Medical Officer, Pharmora
- Matt Jones, Founder & CEO, Digital Quality Associates (DQA)
- Bob Clay, Founder & Managing Director, Highbury Regulatory Science
